Stimulating Peripheral Activity to Relieve Conditions (SPARC): Pre-clinical Development of Existing Market-approved Devices to Support New Market Indications
This NIH Funding Opportunity Announcement (FOA) is part of the Stimulating Peripheral Activity to Relieve Conditions (SPARC) Common Fund program. This FOA invites applications exclusively for non-clinical tests in animal models to obtain safety and efficacy data that support new market indications for a limited set of neuromodulation devices. Partnering companies have agreed to provide neuromodulation technology to investigators supported by the SPARC program. Pre-clinical developments supported by this FOA are expected to generate the necessary safety and efficacy evidence to enable an Investigational Device Exemption (IDE) submission for a future pilot clinical study.
- Pre-Application Submission: Nov. 21, 2016
- Application Submission: 5:00 PM local time of applicant organization, Dec. 16, 2016
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.